
    
      Newly diagnosed histologically confirmed CD20 positive previously untreated diffuse large
      B-cell lymphoma to receive up to 4-6 cycles (21 day cycles) of:

      R-CHOP: Rituximab 375 mg/m2 IV infusion Day 1 Cyclophosphamide 750 mg/m2 IV Day 1 Doxorubicin
      50 mg/m2 IV Day 1 Vincristine 1.4 mg/m2 IV Day 1 (cap @ 2mg) Prednisone 100mg PO daily Days
      1-5 Pegfilgrastim 6 mg subcutaneously within 72 if start if cycle Metformin 500 mg PO daily
      Cycle 1 Days 1-7 Metformin 500 mg PO twice daily Cycle 1 Days 7-21 Metformin 850 mg PO twice
      daily starting on day 22 and and continuing throughout remainder of cycles plus 22 days post
      treatment.

      Restaging will be done after the 4th cycle is complete. Subjects will be monitored with labs
      and physical exams throughout the study.
    
  